BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 21250399)

  • 1. Magnitude and economic effect of overuse of antisecretory therapy in the ambulatory care setting.
    Heidelbaugh JJ; Goldberg KL; Inadomi JM
    Am J Manag Care; 2010 Sep; 16(9):e228-34. PubMed ID: 21250399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of proton pump inhibitors with lack of diagnostic indications in 22 Midwestern US skilled nursing facilities.
    Patterson Burdsall D; Flores HC; Krueger J; Garretson S; Gorbien MJ; Iacch A; Dobbs V; Homa T
    J Am Med Dir Assoc; 2013 Jun; 14(6):429-32. PubMed ID: 23583000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is there overuse of proton pump inhibitors in B-cell non-Hodgkin lymphomas? A cohort study based on the French health insurance database in the Midi-Pyrénées region.
    Conte C; Bourrel R; Despas F; Lapeyre-Mestre M
    Fundam Clin Pharmacol; 2019 Jun; 33(3):327-338. PubMed ID: 30625254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of proton pump inhibitors in an Italian hospital: focus on oncologic and critical non-ICU patients.
    Meli M; Raffa MP; Malta R; Morreale I; Aprea L; D'Alessandro N
    Int J Clin Pharm; 2015 Dec; 37(6):1152-61. PubMed ID: 26319396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Inappropriate Prescription of Oral Proton Pump Inhibitors in the Hospital Setting: A Prospective Cross-Sectional Study.
    Kelly OB; Dillane C; Patchett SE; Harewood GC; Murray FE
    Dig Dis Sci; 2015 Aug; 60(8):2280-6. PubMed ID: 25840918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous Proton Pump Inhibitor Therapy and the Associated Risk of Recurrent Clostridium difficile Infection.
    McDonald EG; Milligan J; Frenette C; Lee TC
    JAMA Intern Med; 2015 May; 175(5):784-91. PubMed ID: 25730198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inappropriate use of proton pump inhibitors in a local setting.
    Chia CT; Lim WP; Vu CK
    Singapore Med J; 2014 Jul; 55(7):363-6. PubMed ID: 25091884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton pump inhibitor utilisation and potentially inappropriate prescribing analysis: insights from a single-centred retrospective study.
    Liu Y; Zhu X; Li R; Zhang J; Zhang F
    BMJ Open; 2020 Nov; 10(11):e040473. PubMed ID: 33243802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton pump inhibitor use in the U.S. ambulatory setting, 2002-2009.
    Rotman SR; Bishop TF
    PLoS One; 2013; 8(2):e56060. PubMed ID: 23418510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of proton pump inhibitors in adults in France: a nationwide drug utilization study.
    Lassalle M; Le Tri T; Bardou M; Biour M; Kirchgesner J; Rouby F; Dumarcet N; Zureik M; Dray-Spira R
    Eur J Clin Pharmacol; 2020 Mar; 76(3):449-457. PubMed ID: 31838548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.
    Leontiadis GI; Sreedharan A; Dorward S; Barton P; Delaney B; Howden CW; Orhewere M; Gisbert J; Sharma VK; Rostom A; Moayyedi P; Forman D
    Health Technol Assess; 2007 Dec; 11(51):iii-iv, 1-164. PubMed ID: 18021578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prescribing of proton pump inhibitors for gastrointestinal bleeding prophylaxis in the Lebanese outpatient setting: patterns, compliance with guidelines and risks.
    Soubra L; Issa M
    Int J Pharm Pract; 2019 Aug; 27(4):386-392. PubMed ID: 30942513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterizing Potentially Inappropriate Prescribing of Proton Pump Inhibitors in Older People in Primary Care in Ireland from 1997 to 2012.
    Moriarty F; Bennett K; Cahir C; Fahey T
    J Am Geriatr Soc; 2016 Dec; 64(12):e291-e296. PubMed ID: 27996115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential costs of inappropriate use of proton pump inhibitors.
    Ladd AM; Panagopoulos G; Cohen J; Mar N; Graham R
    Am J Med Sci; 2014 Jun; 347(6):446-51. PubMed ID: 24270078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of large scale, multicomponent intervention to reduce proton pump inhibitor overuse in integrated healthcare system: difference-in-difference study.
    Kurlander JE; Laine L; Kim HM; Roberts CB; Saffar D; Myers A; Holleman R; Gao Y; Shank M; Nelson R; Forman J; Helfrich CD; Krein SL; Saini SD; Yang YX
    BMJ; 2024 Apr; 385():e076484. PubMed ID: 38604668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and Risk Factors for Inappropriate Continuation of Proton Pump Inhibitors After Discharge From the Intensive Care Unit.
    Blackett JW; Faye AS; Phipps M; Li J; Lebwohl B; Freedberg DE
    Mayo Clin Proc; 2021 Oct; 96(10):2550-2560. PubMed ID: 33308869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Four-year trends of inappropriate proton pump inhibitor use after hospital discharge.
    Leri F; Ayzenberg M; Voyce SJ; Klein A; Hartz L; Smego RA
    South Med J; 2013 Apr; 106(4):270-3. PubMed ID: 23558416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inappropriate proton-pump inhibitor prescribing in primary care - an observational study with quality circles.
    Vidonscky Lüthold R; Henz NC; Fuhrer C; Häner A; Schenk M; Jungo KT; Streit S
    Swiss Med Wkly; 2023 Sep; 153():40119. PubMed ID: 37769322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Proton bomb inhibitors: a study of the prescription in a functional recovery unit].
    López-Dóriga Bonnardeaux P; Neira Álvarez M; Mansilla Laguía S
    Rev Esp Geriatr Gerontol; 2013; 48(6):269-71. PubMed ID: 24099902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inappropriate use of proton pump inhibitors in hospitalized patients with lower gastrointestinal bleeding.
    Quinn AJ; Saven H; Haile R; Moon SJ; Lee A; Thor S
    Hosp Pract (1995); 2024; 52(1-2):19-22. PubMed ID: 38407180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.